MAPK3 and colorectal carcinoma: CO-IP assays showed that Lyn interacted with ERK1/2 in a CD24 high expression cell line and the Lyn-ERK interaction was disrupted by the depletion of CD24, suggesting that Lyn was involved in CD24-induced ERK1/2 activation in CRC cells.